Why IMU is a multi multi bagger, page-5040

@fourdollars There was a delay because the original version of HER-Vaxx was re-engineered because when the first ph1 was run, it wasn't as efficacious as they wanted. The newer version is significantly better and is running on a reasonable timeframe. (I'm sure we would all like it to progress quicker however drug trials generally take longer than hoped for.) So you are correct about the six years but you failed to include important information that explains the delay.

I interpreted the lack of results to indicate the first phase of the trial had ended but the report had not yet been written and peer reviewed. That will take some time and it would not be appropriate to hold up the progression of the trial so they could release the formal results at the same time. We will see results at some point in the future however they may not write the report until the completion of the second phase of the trial. LC can only announce information that the trial investigator has released to IMU so it's unrealistic to expected information should have been provided in the announcement when it may not have been made available to the company.